Acneiform Eruptions: Clinical Trials

797 trials for Acneiform Eruptions, newest first
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

561 completed, 103 unknown, 36 not yet recruiting, 32 recruiting. 206 Not applicable, 147 Phase 2, 139 Phase 3, 125 Phase 4, 105 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable206Completed 118, Unknown 42, Not yet recruiting 12, Recruiting 10, Terminated 10, Withdrawn 9, Active not recruiting 5
Phase 2147Completed 104, Unknown 17, Not yet recruiting 8, Terminated 7, Active not recruiting 4, Recruiting 3, Withdrawn 3, Enrolling by invitation 1
Phase 3139Completed 112, Unknown 10, Recruiting 4, Active not recruiting 3, Not yet recruiting 3, Terminated 3, Withdrawn 3, Enrolling by invitation 1
Phase 4125Completed 95, Unknown 13, Recruiting 5, Terminated 4, Not yet recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 1105Completed 90, Unknown 6, Recruiting 3, Active not recruiting 2, Not yet recruiting 2, Withdrawn 2
Early Phase 115Completed 7, Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1

Follow Acneiform Eruptions: new trials by email Literature Review of Acneiform Eruptions trials Research Report on Acneiform Eruptions

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Akkermansia Muciniphila in Acne Vulgaris
Akkermansia Muciniphila, Clostridium Beijerinckii, Anaerobutyricum Hallii, Clostridium Butyricum, Bifidobacterium Infantis Probiotic Capsule - Acne		Early Phase 1Not yet recruitingMedical University of South Carolina342027-03-012026-05-12
Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.
Fractional co2 laser, Botulinium Toxin-A - Acne, Acne Papulopustulosa		Phase 3Not yet recruitingCairo University242026-11-062026-11-05
Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne
Clascoterone 1% cream, Clindamycin 1% lotion, Adapalene 0.1%/benzoyl peroxide 2.5% gel - Acne Vulgaris		Phase 4Not yet recruitingAllied Hospital Faisalabad1182026-11-012026-10-19
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne
Acne mRNA (messenger ribonucleic acid) vaccine, Placebo - Acne		Phase 2Not yet recruitingSanofi4102026-10-302026-09-18
Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical Tretinoin
oil-balancing sunscreen - Acne		Phase 4Enrolling by invitationColgate Palmolive402026-10-282026-11-12
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Denifanstat, Placebo - Acne Vulgaris		Phase 3RecruitingSagimet Biosciences Inc.8002026-10-212026-11-09
Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris
Clascoterone 1% cream, Adapalene 0.1% cream - Acne Vulgaris		Not applicableRecruitingPak Emirates Military Hospital1302026-10-082026-10-22
Study to Determine Efficacy, Safety, and Tolerability of B244 as a Topical Spray in Subjects With Moderate to Severe Acne Vulgaris
B244, Vehicle - Acne Vulgaris		Phase 2Not yet recruitingAOBiome LLC1762026-10-012026-10-08
Demodex Mites in Acne Patients and Herbal Extract Susceptibility
Acne, Demodex Infestation		Not yet recruitingAssiut University802026-09-262026-09-28
Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne
nadifloxacin, Tretinoin Cream 0.025%, Clindamycin - Acne Vulgaris		Phase 4RecruitingNishtar Medical University1582026-09-172026-11-04
Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris
Adapalene 0.1% and Benzoyl Peroxide 2.5% gel, Sequential Radiofrequency Treatment - Acne Vulgaris		Not applicableRecruitingJeisys Medical Inc602026-09-152026-09-04
Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation
Probiotics, Placebo - Acne Vulgaris		Not applicableNot yet recruitingFoundation University Islamabad642026-09-012026-04-20
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Flexible ePROM-guided Scheduling System, electronic patient reported outcome measures (ePROMs) - Chronic Dermatological Conditions, Eczema		Not applicableNot yet recruitingNational University Hospital, Singapore2502026-09-012026-07-01
Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation
Vinoperfect brightening serum - Post-inflammatory Hyperpigmentation, Post-acne Hyperpigmentation		Not applicableNot yet recruitingWeill Medical College of Cornell University202026-09-012026-10-30
Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway
Isotretinoin, Doxycycline, Blood specimen collection - Acneiform Drug Eruption, Acneiform Eruptions		Phase 2Not yet recruitingUniversity of California, San Francisco502026-08-302026-06-05
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Experimental drug (Cyproterone Acetate 2 mg and Ethinyl Estradiol 0.02 mg), Placebo - Acne Vulgaris, Acne Vulgaris on the Face		Phase 3RecruitingEurofarma Laboratorios S.A.5312026-08-242026-10-27
Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris
Clascoterone Cream 1%, Adapalene 0,1% cgel - Acne Vulgaris		Early Phase 1Not yet recruitingKhyber Teaching Hospital602026-08-152026-06-29
Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital
Polyendocrine Metabolic Ovarian Syndrome, Acne Vulgaris		RecruitingSohag University902026-08-092026-09-16
Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris
Zn(II)-phthalocyanine gel - Acne		Not applicableNot yet recruitingUniversità degli Studi di Brescia102026-08-012026-05-04
Clinical Observation of Skin Condition in Patients With Acne Vulgaris Using Ubiquinol, Pomegranate Peel Extract, Ceramide, and Salicylic Acid Emulsion
Acne		Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University402026-07-202026-07-29

Showing 20 of 797. Sign in to see all of them.

Narrower conditions

Acne Vulgaris (783)  ·  Cicatrix (18)  ·  Psoriasis (15)  ·  Dermatitis, Atopic (13)  ·  Rosacea (13)  ·  Hyperpigmentation (12)  ·  Skin Diseases (10)  ·  Eczema (9)  ·  Acne Keloid (8)  ·  Dermatitis (8)  ·  Hidradenitis Suppurativa (8)  ·  Alopecia (7)  ·  Dermatitis, Seborrheic (6)  ·  Facies (5)

Broader conditions

Skin and Connective Tissue Diseases (797)  ·  Skin Diseases (787)  ·  Sebaceous Gland Diseases (782)  ·  Pathological Conditions, Signs and Symptoms (60)  ·  Pathologic Processes (43)  ·  Skin Diseases, Eczematous (25)  ·  Immune System Diseases (23)  ·  Dermatitis (22)  ·  Hair Diseases (22)  ·  Infections (21)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (20)  ·  Skin Diseases, Papulosquamous (20)  ·  Fibrosis (19)  ·  Hypersensitivity (19)

Interventions

Adapalene (64)  ·  Gels (64)  ·  Benzoyl Peroxide (51)  ·  Clindamycin (37)  ·  Isotretinoin (31)  ·  Tretinoin (29)  ·  Doxycycline (25)  ·  Adapalene, Benzoyl Peroxide Drug Combination (21)  ·  Dapsone (19)  ·  tazarotene (17)  ·  Clascoterone (16)  ·  Minocycline (15)  ·  clindamycin phosphate (15)  ·  berdazimer sodium (13)  ·  clindamycin phosphate benzoyl peroxide combination (13)

Sponsors

Galderma R&D (45)  ·  Stiefel, a GSK Company (29)  ·  Bausch Health Americas, Inc. (27)  ·  Sun Pharmaceutical Industries, Inc. (22)  ·  Assiut University (18)  ·  Cosmetique Active International (13)  ·  GlaxoSmithKline (13)  ·  Novan, Inc. (13)  ·  Allergan (11)  ·  Integrative Skin Science and Research (9)  ·  Pierre Fabre Dermo Cosmetique (9)  ·  Sohag University (9)  ·  Almirall, S.A. (8)  ·  Bayer (8)  ·  Cairo University (7)

Countries

United States (377)  ·  Canada (59)  ·  Egypt (38)  ·  China (36)  ·  France (24)  ·  Poland (24)  ·  Germany (18)  ·  Spain (17)  ·  Brazil (16)  ·  Indonesia (15)  ·  Israel (13)  ·  Turkey (Türkiye) (13)  ·  Belize (12)  ·  Australia (11)  ·  Pakistan (11)

Top investigators

Anya Loncaric (13)  ·  Michael Graeber, MD (7)  ·  Natalie Yantovskiy (6)  ·  John J Voorhees, MD (5)  ·  Joyce Rico, MD (5)  ·  Anya Loncaric, MS (4)  ·  Beth Zib (4)  ·  Robert Bissonnette, MD (4)  ·  Amy Paller, MD (3)

Results publications

PMID 40377868, PMID 20684151, PMID 27518661, PMID 27847545, PMID 29380251, PMID 30500139, PMID 30500140, PMID 30500141, PMID 32320027, PMID 32886337, PMID 34607697, PMID 36745367, PMID 38724841, PMID 39141589, PMID 10951254, PMID 11488820, PMID 12095065, PMID 12243706, PMID 12553848, PMID 12839559, PMID 16247244, PMID 16575387, PMID 1699862, PMID 17314442, PMID 17616769, PMID 18249468, PMID 18394082, PMID 18472984, PMID 18532922, PMID 18720689, PMID 18827119, PMID 19075138, PMID 19376456, PMID 19439902, PMID 19746769, PMID 19911678, PMID 20213916, PMID 20214175, PMID 20404229, PMID 20677537, PMID 20981308, PMID 21108671, PMID 21143923, PMID 21288628, PMID 21572783, PMID 21880356, PMID 22168326, PMID 22253996, PMID 22341881, PMID 22678562

NIH funding

2023 (4), 2025 (3), 2016 (2), 2014 (1), 2017 (1), 2018 (1), 2019 (1), R01AR053542 (1), R01HD065029 (1), U01AR079752 (1)